Statistics
Publications
3
Citations
90
H-Index
3
Active since
2020
Affiliations
Hubei University of Chinese Medicine(Current)
Ruochan Li is an author at Hubei University of Chinese Medicine specializing in oncology, molecular oncology, and pharmacology.
Publications per year
2020–2023
3
3
Dihydroartemisinin inhibits angiogenesis in breast cancer via regulating VEGF and MMP‐2/‐9
Qi Rao, Yu He, Ruochan Li et al. · Fundamental and Clinical Pharmacology · 2023 · 31 citations
Medicine, Oncology, Pharmacology +13
Qi Rao, Ruochan Li, Yu He et al. · Oncology Letters · 2022 · 12 citations · Full text
Medicine, Oncology, Pharmacology +16
1–3 of 3